| Product |
CAS |
Molecular formula |
More |
| Tert-butyl 4-((6-(5-nitro-1h-indol-1-yl)pyrimidin-4-yl)oxy)piperidine- |
1361195-76-7 |
C22H25N5O5 |
More |
| N,n-dimethyl-4-((6-(5-(methylsulfonyl)-1h-indol-1-yl)pyrimidin-4-yl)ox |
1361195-47-2 |
C21H25N5O4S |
More |
| Isopropyl 4-((6-(5-(methylsulfonyl)-1h-indol-1-yl)pyrimidin-4-yl)oxy)p |
1361195-50-7 |
C22H26N4O5S |
More |
| Tert-butyl 4-((6-(5-(methylsulfonyl)-1h-indol-1-yl)pyrimidin-4-yl)oxy) |
1361195-21-2 |
C23H28N4O5S |
More |
| Tert-butyl 4-((6-(3-methyl-5-(methylsulfonyl)-1h-indol-1-yl)pyrimidin- |
1361195-32-5 |
C24H30N4O5S |
More |
| Tert-butyl 4-(((6-(5-(methylsulfonyl)-1h-indol-1-yl)pyrimidin-4-yl)oxy |
1361195-68-7 |
C24H30N4O5S |
More |
| Tert-butyl 4-((2-methyl-6-(5-(methylsulfonyl)-1h-indol-1-yl)pyrimidin- |
1361195-27-8 |
C24H30N4O5S |
More |
| Tert-butyl 4-((5-methoxy-6-(5-(methylsulfonyl)-1h-indol-1-yl)pyrimidin |
1361195-36-9 |
C24H30N4O6S |
More |
| Tert-butyl 4-((2-methyl-6-(3-methyl-5-(methylsulfonyl)-1h-indol-1-yl)p |
1361195-33-6 |
C25H32N4O5S |
More |
| 5-(Methylsulfonyl)-1-(6-(piperidin-4-yloxy)pyrimidin-4-yl)-1h-indole h |
1361195-73-4 |
C18H20N4O3S.HCL |
More |
| 5-(Methylsulfonyl)-1-(6-(piperidin-4-yloxy)pyrimidin-4-yl)-1h-indole |
1361294-71-4 |
C18H20N4O3S |
More |
| 1-((Tetrahydrofuran-2-yl)methyl)-1h-indole |
1146636-58-9 |
C13H15NO |
More |
| 1-((Tetrahydrofuran-2-yl)methyl)indoline-2,3-dione |
1275951-04-6 |
C13H13NO3 |
More |
| 7-(Benzyloxy)chroman |
1373242-85-3 |
C16H16O2 |
More |
| N-(2-bromophenyl)-2-methylbenzofuran-3-carboxamide |
1373243-63-0 |
C16H12BrNO2 |
More |
| Methyl 3-hydroxy-6-methylpyridine-2-carboxylate |
61548-52-5 |
C8H9NO3 |
More |
| 1-Benzhydryl-3-(2,4-dihydroxyphenyl)-3-hydroxyindolin-2-one |
1373242-47-7 |
C27H21NO4 |
More |
| 5-(3-Bromo-4-methylphenyl)-1,3,4-oxadiazol-2(3h)-one |
671794-35-7 |
C9H7BrN2O2 |
More |
| 3-(3-Bromo-4-methylphenyl)-5,5-dimethyl-4,5-dihydroisoxazole |
1373940-27-2 |
C12H14BrNO |
More |
| 5-(3-Bromo-4-methylphenyl)-3-methyl-1,3,4-oxadiazol-2(3h)-one |
1373940-06-7 |
C10H9BrN2O2 |
More |
